Tivoxavir Marboxil (TRX-02)
Influenza (Seasonal and Avian)
Phase 2Active
Key Facts
About Traws Pharma
Traws Pharma is a US-based, clinical-stage biotech advancing two distinct oral antiviral programs: ratutrelvir for COVID-19/Long COVID and tivoxavir marboxil for influenza. The company's strategy targets specific viral enzymes to overcome resistance and aims for convenient, ritonavir-free or single-dose regimens. Led by a seasoned team with deep virology and drug development experience, Traws is navigating the competitive and rapidly evolving antiviral therapeutics market.
View full company profile